New ZERO360 Helpline Ensures No Man Faces Prostate Cancer Alone FOR IMMEDIATE RELEASEMedia Contact:Stephanie S. JohnsonZERO Prostate Cancerstephjohnson@zerocancer.org | media@zerocancer.org(202) 998-2507 New ZERO360 Helpline Offers Resources, Guidance, and Support to patients and families impacted by prostate cancer Alexandria, VA.—ZERO Prostate Cancer (ZERO), announced today that its new comprehensive patient support helpline, ZERO360, is now toll-free to patients and families facing prostate cancer at 1-844-ZERO360. This vital service is made possible through the generous support of AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson, with AstraZeneca sponsoring both ZERO360 and ZERO’s Peer Support programs. From insurance navigation and medication co-pay assistance to financial relief for daily living expenses, counseling referrals, and benefits advocacy, ZERO360 case managers provide expert, compassionate guidance every step of the way. In addition to addressing urgent financial and logistical barriers, ZERO360 also connects callers to ZERO’s robust Peer Support network, which includes over 160 support groups across the country, and its MENtor program. These programs, powered by lead sponsor Pfizer and supported by AstraZeneca, pair men with trained survivors and caregivers who help address treatment side effects, stigma in healthcare, and the emotional toll of prostate cancer, ensuring no patient or care partner ever faces this disease alone. “As the nation’s leading provider of prostate cancer resources, programs, and services, ZERO is committed to making sure every man and family has access to the help they deserve when they need it most,” said Brian Bragg, Chief Mission Officer at ZERO Prostate Cancer. “ZERO360 is more than a helpline. It’s a gateway to financial stability, emotional resilience, and a connected community of survivors and caregivers who provide strength and hope.”"Pfizer is proud to support ZERO’s peer support programs, which are vital in helping patients and caregivers find community, strength, and hope as they navigate the prostate cancer journey,” said Marianne Gandee, Vice President, Oncology Patient Solutions & Alliances, Pfizer Oncology. “We are proud to work alongside advocacy leaders , like ZERO, to close gaps in access and improve the lived experience of all those impacted by cancer.”“Behind every call to ZERO360 is a man or family searching for hope, clarity, and support while facing the uncertainty of this disease,” said Daniele Paone, Vice President of the GYN/GU Cancer Franchise at AstraZeneca. “We’re proud to partner with ZERO to expand these lifesaving programs and break down barriers so that every man, no matter his zip code, has access to resources, guidance, and support needed to not only survive prostate cancer but thrive.”To access free, confidential support, call 1-844-ZERO360 or visit www.zerocancer.org/ZERO360.About Pfizer OncologyAt Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes three core mechanisms of action to attack cancer from multiple angles, including small molecules, antibody-drug conjugates (ADCs), and bispecific antibodies, including other immune-oncology biologics. We are focused on delivering transformative therapies in some of the world’s most common cancers, including breast cancer, genitourinary cancer, hematology-oncology, and thoracic cancers, which include lung cancer. Driven by science, we are committed to accelerating breakthroughs to help people with cancer live better and longer lives. Our Ambition: Cancer is one of the most challenging health crises of our lifetime. Despite significant advancements, millions of people globally receive a cancer diagnosis each year. At Pfizer, we’ve shown how we can move with urgency to deliver breakthroughs that change patients’ lives. And now, we’re making significant investments to outdo cancer — nothing is more urgent, or more personal, than our goal to outpace, outsmart and outmaneuver cancer at every turn. Our vision is a world where people with cancer live better and longer lives. We are accelerating breakthrough cancer medicines that bring new hope to patients everywhere.About Johnson & JohnsonAt Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more at https://www.jnj.com or at www.innovativemedicine.jnj.com. Janssen Research & Development, LLC, and Janssen Biotech, Inc., are Johnson & Johnson companies. About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org More for Press & Media Press Releases Press Releases Explore our newsroom for press releases and official statements about ZERO's latest updates, achievements, and partnerships. Press & Media Inquiries Press & Media Inquiries See how to contact ZERO's media contacts for press inquiries, logo and brand guidelines, and our recent press releases. Media Kits Media Kits Find essential tools to enhance your storytelling and coverage about ZERO. Press Release
FOR IMMEDIATE RELEASEMedia Contact:Stephanie S. JohnsonZERO Prostate Cancerstephjohnson@zerocancer.org | media@zerocancer.org(202) 998-2507
New ZERO360 Helpline Offers Resources, Guidance, and Support to patients and families impacted by prostate cancer Alexandria, VA.—ZERO Prostate Cancer (ZERO), announced today that its new comprehensive patient support helpline, ZERO360, is now toll-free to patients and families facing prostate cancer at 1-844-ZERO360. This vital service is made possible through the generous support of AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson, with AstraZeneca sponsoring both ZERO360 and ZERO’s Peer Support programs. From insurance navigation and medication co-pay assistance to financial relief for daily living expenses, counseling referrals, and benefits advocacy, ZERO360 case managers provide expert, compassionate guidance every step of the way. In addition to addressing urgent financial and logistical barriers, ZERO360 also connects callers to ZERO’s robust Peer Support network, which includes over 160 support groups across the country, and its MENtor program. These programs, powered by lead sponsor Pfizer and supported by AstraZeneca, pair men with trained survivors and caregivers who help address treatment side effects, stigma in healthcare, and the emotional toll of prostate cancer, ensuring no patient or care partner ever faces this disease alone. “As the nation’s leading provider of prostate cancer resources, programs, and services, ZERO is committed to making sure every man and family has access to the help they deserve when they need it most,” said Brian Bragg, Chief Mission Officer at ZERO Prostate Cancer. “ZERO360 is more than a helpline. It’s a gateway to financial stability, emotional resilience, and a connected community of survivors and caregivers who provide strength and hope.”"Pfizer is proud to support ZERO’s peer support programs, which are vital in helping patients and caregivers find community, strength, and hope as they navigate the prostate cancer journey,” said Marianne Gandee, Vice President, Oncology Patient Solutions & Alliances, Pfizer Oncology. “We are proud to work alongside advocacy leaders , like ZERO, to close gaps in access and improve the lived experience of all those impacted by cancer.”“Behind every call to ZERO360 is a man or family searching for hope, clarity, and support while facing the uncertainty of this disease,” said Daniele Paone, Vice President of the GYN/GU Cancer Franchise at AstraZeneca. “We’re proud to partner with ZERO to expand these lifesaving programs and break down barriers so that every man, no matter his zip code, has access to resources, guidance, and support needed to not only survive prostate cancer but thrive.”To access free, confidential support, call 1-844-ZERO360 or visit www.zerocancer.org/ZERO360.About Pfizer OncologyAt Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes three core mechanisms of action to attack cancer from multiple angles, including small molecules, antibody-drug conjugates (ADCs), and bispecific antibodies, including other immune-oncology biologics. We are focused on delivering transformative therapies in some of the world’s most common cancers, including breast cancer, genitourinary cancer, hematology-oncology, and thoracic cancers, which include lung cancer. Driven by science, we are committed to accelerating breakthroughs to help people with cancer live better and longer lives. Our Ambition: Cancer is one of the most challenging health crises of our lifetime. Despite significant advancements, millions of people globally receive a cancer diagnosis each year. At Pfizer, we’ve shown how we can move with urgency to deliver breakthroughs that change patients’ lives. And now, we’re making significant investments to outdo cancer — nothing is more urgent, or more personal, than our goal to outpace, outsmart and outmaneuver cancer at every turn. Our vision is a world where people with cancer live better and longer lives. We are accelerating breakthrough cancer medicines that bring new hope to patients everywhere.About Johnson & JohnsonAt Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more at https://www.jnj.com or at www.innovativemedicine.jnj.com. Janssen Research & Development, LLC, and Janssen Biotech, Inc., are Johnson & Johnson companies.
About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org
More for Press & Media Press Releases Press Releases Explore our newsroom for press releases and official statements about ZERO's latest updates, achievements, and partnerships. Press & Media Inquiries Press & Media Inquiries See how to contact ZERO's media contacts for press inquiries, logo and brand guidelines, and our recent press releases. Media Kits Media Kits Find essential tools to enhance your storytelling and coverage about ZERO.
